INNODIA Family & Friends Early-Stage Type 1 Diabetes Detection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project invites family members and close friends of people diagnosed with symptomatic Type 1 diabetes before age 45 to give consent and a blood sample. Researchers test the blood for diabetes-related autoantibodies that indicate early, preclinical stages of T1D. Participants are recruited at clinical sites in Leuven, Paris, and Milan and may be followed over time if antibodies are detected. The resulting registry of at-risk individuals is intended to support monitoring and future prevention efforts.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Have given written informed consent to participate
2. Be aged between 1 and 45 years
3. Have a family relative with T1D or close friend diagnosed with symptomatic T1D at age \<45 years

Exclusion Criteria:

1. Previous diagnosis of stage 3 T1D or other forms of diabetes
2. Unable/unwilling to consent to participation

Where it's running

• Medical University of Vienna
  Vienna, Austria Recruiting
• Katholieke Universiteit Leuven
  Leuven, Belgium Recruiting
• Motol University Hospital
  Prague, Czechia Recruiting
• Angers University Hospital Center (CHU Angers)
  Angers, France Recruiting
• Avicenne Hospital
  Bobigny, France Recruiting
• Jean Verdier Hospital
  Bondy, France Recruiting

Study contacts

• Study coordinator: Laura Moreno Belmonte
• Email: laura.moreno@innodia.org
• Phone: +393889544246

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UK islet autoantibody registry for early Type 1 diabetes

  This UK registry collects health and antibody information from people with one or more islet autoantibodies to track who develops Type 1 diabetes and to connect them with monitoring or prevention options.

  Recruiting University of Oxford · Oxford, Oxfordshire · NCT07125365

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic

  This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.

  Recruiting at 3 sites Life for a Child Program, Diabetes Australia · Santiago de los Caballeros and 2 other locations · NCT07742306

• AI-assisted remote insulin pump optimization for people with type 1 diabetes

  This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.

  Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07732777

• High-Intensity Interval Training vs. Continuous Endurance Training in Prediabetes

  This study tests whether short bursts of intense exercise or steady, longer workouts can improve blood sugar control and fitness in people with prediabetes.

  Recruiting Riphah International University · Lahore, Punjab Province · NCT07713030

• AMX0035 in adults with Type 1 Diabetes

  This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.

  Recruiting Phase 2 University of Washington · Seattle, Washington and 1 other locations · NCT07699380

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.